Reliefband Technologies LLC, a trailblazer in neuromodulation, has developed the first FDA-cleared, clinically proven wearable device to address nausea and vomiting associated with various conditions. Founded in 2015, the company's flagship product, Reliefband, operates by stimulating a nerve on the wrist, effectively signaling the brain to alleviate nausea without adverse side effects. This innovative solution caters to individuals experiencing seasickness, motion sickness, migraines, anxiety, and more. The last investment of $5.00M in a Venture Round, dated December 15, 2015, was secured from PathoCapital. Reliefband Technologies operates at the intersection of Hardware, Health Care, Information Technology, and Medical Devices, highlighting its commitment to addressing diverse challenges within the healthcare and wellness space. Based in the United States, the company's slogan "The Anti-Nausea Wristband helping you overcome life's uncomfortable moments" encapsulates its mission to provide effective, accessible relief for individuals facing debilitating symptoms.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Venture Round | $5.00M | 1 | PathoCapital | 15 Dec 2015 |
No recent news or press coverage available for Reliefband Technologies LLC.